Benign, but not harmless. Meningiomas in focus

Sabine’s success with Cyberknife® in Salzburg

A patient successfully treated with Cyberknife® recently visited the Cyberknife® Center in Salzburg for a follow-up examination with Dr. Alfred Haidenberger.

Sabine shares her story with us.

It was a moment of shock when Sabine had her first epileptic seizure. The cause was quickly found: a benign meningioma in the temporal lobe was the trigger. But what exactly is that?

Meningiomas explained.

Meningiomas are benign tumors of the central nervous system. They develop from the cells of the meninges, which surround the brain and spinal cord. Although they usually grow slowly and do not metastasize, their volume can displace sensitive brain or spinal nerves – sometimes resulting in significant neurological symptoms. The frequency of this diagnosis increases with age, occurring more often in women than in men.

Precise and gentle:
Cyberknife® therapy in Salzburg.

Following the diagnosis, Sabine looked for a treatment that was effective, low-risk, and gentle – and found Cyberknife® Salzburg.

Following a detailed consultation with Dr. Alfred Haidenberger, she chose the state-of-the-art Cyberknife® therapy. The system enables high-dose radiation of the tumor with millimeter precision, without damaging the surrounding healthy tissue. The treatment is non-invasive, completely without a scalpel, painless, and usually completed in a single session lasting approximately 20 minutes.

Especially for patients for whom surgery would involve an increased risk of neurological impairment, Cyberknife® offers an effective, low-risk alternative with a high success rate.

A new chapter for Sabine.

Six months after the treatment, Sabine is living a conscious, relieved life! Her example shows how precise and gentle treatment with the Cyberknife® is – and that benign does not always mean harmless.

Article by Petra Ruso, October 5, 2025